亚洲人av在线丨国产山村乱淫老妇女视频丨爱情岛论坛自拍丨久久亚洲精品小早川怜子丨日韩国产成人精品视频丨大陆av在线丨老司机成人永久免费视频丨国产精品亚洲精品日韩动图丨欧美人牲交a欧美精区日韩丨无码国内精品久久人妻丨伊人网在线视频观看丨亚洲欧美色一区二区三区丨欧美一级做a爰片免费视频丨伊人久久一区二区三区无码丨忍不住的亲子中文字幕丨蜜臀av在线播放丨精品欧美一区二区精品久久丨天天爱天天舔丨久久av免费这里有精品丨加勒比中文无码久久综合色丨中文字幕亚洲日本丨你懂的在线观看网址丨精品免费在线视频丨色噜噜狠狠色综合免费视频丨一级全黄少妇免费录像片

Output value of biomedical industry in SIP reaches RMB 90 billion in 2019

SIP started deployment for biomedical industry in 2007. Since then, the industry has maintained an annual growth of more than 20% in total output value, which reached RMB 90 billion last year. This has enabled SIP to rank among the country’s best clusters of biomedicine businesses. Statistics show that SIP recorded a long list of new drugs that received approvals last year for clinical trials, which account for 10% of the national total, and of them, new biological drugs developed in SIP accounted for 20% of the national total.[MORE]